SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
780YM by hbomb: better link for multiple myelome MET rationale 26-Jun-11 02:47IRWIN JAMES FRANKEL-6/26/2011
779From a patient in clinical on XL184 for MTC: I was found to have "progressIRWIN JAMES FRANKEL-6/22/2011
778Well that is all consistent with statements from EXEL management. Gisela SchwabIRWIN JAMES FRANKEL-6/19/2011
777Maybe I am being unduly pessimistic on an SPA. This from pharmawire: <i>EBiomaven-6/18/2011
776YM by oncodoc Just for fun here are a few more thoughts about Cabo toxicity: 1IRWIN JAMES FRANKEL-6/17/2011
775thats why we use risk reward if we're smart :-p cheers Stefaandalroi-6/17/2011
774<i> certainly warrant an investment</i> Doctors (and dentists) makeBiomaven-6/14/2011
773YM by Kaplanbarry39 The problem with your opinion is that you do not appear to IRWIN JAMES FRANKEL-6/14/2011
772>> might go faster given that top level people at the FDA cancer unit partBiomaven-6/14/2011
771>>Even if they do, negotiations will take forever. That is unfortunate. IRWIN JAMES FRANKEL-6/14/2011
770<i>a favorable SPA</i> I really wonder if the FDA will give them anBiomaven-6/13/2011
769I wouldn't assume she was on drug. Maybe if pleural effusions are a known rkrw-6/13/2011
768YM posted by i-rat: Data good, hang in there,,, 13-Jun-11 06:34 pm FromIRWIN JAMES FRANKEL-6/13/2011
767>>I think until there's clarity that 184 will extend survival in prostIRWIN JAMES FRANKEL-6/13/2011
766There have also been recent examples of bios on the block being overpriced and nrkrw-6/13/2011
765YM kaplanbarry39 The spot is the bladder and quite normal in bone scans. All paIRWIN JAMES FRANKEL-6/13/2011
764YM earnie to oncodoc <<If they are able to announce the trial design and IRWIN JAMES FRANKEL-6/13/2011
763<i> I gather that the side effects problem is indeed serious.</i> NBiomaven-6/13/2011
762I gather that the side effects problem is indeed serious. After dropping as a reChris0816/10/2011
761>>I was planning to ask you if you had been following the posters on YahooIRWIN JAMES FRANKEL-6/10/2011
760Yesterday in the Jefferies presentation Gisela Schwab, MD stated that EXEL expecIRWIN JAMES FRANKEL-6/10/2011
759From Medpage Today. CHICAGO -- Two-thirds of men with castration-resistant prosrkrw-6/10/2011
758YM by onchodoc I still haven't made it through all the various presentationIRWIN JAMES FRANKEL16/10/2011
757YM by onchodoc I'd be very careful of a combination trial of Cabo plus anotIRWIN JAMES FRANKEL-6/10/2011
756Why not ask him? I was planning to ask you if you had been following the posterbiofisher16/9/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News